12:11 PM EST, 01/06/2025 (MT Newswires) -- Sunshine Biopharma ( SBFM ) filed a registration statement Monday for the potential sale of up to $100 million of its securities from time to time.

The filing covers the company's common stock, preferred stock, warrants, rights and units.

The company said it plans to use the net proceeds for general corporate purposes, including working capital.

Shares of Sunshine Biopharma ( SBFM ) were down 6.7% in recent Monday trading.

Price: 3.23, Change: -0.23, Percent Change: -6.65